Researcher Image
Mohammed Abdulameer Oleiwi - Mohammed Abdulameer Oleiwi
PhD - lecturer
College of pharmacy , Department of pharmaceutical chemistry
[email protected]
Summary

Summary I obtained a degree in Pharmacy from the University of Baghdad in 2005 and subsequently served as a laboratory instructor at the same institution. After completing my master’s degree in Pharmaceutical Chemistry in 2014, I returned as a faculty member in the Department of Pharmaceutical Chemistry at the University of Baghdad. In 2018, I commenced my Ph.D. studies in Pharmaceutical Chemistry, which I completed in 2022. I currently serve as a faculty member with the rank of Lecturer in the Department of Pharmaceutical Chemistry. I possess over 10 years of experience in Pharmaceutical Chemistry and Drug design researches and have authored 6 publications. Qualifications Ph.D in Pharmaceutical Chemistry Master in Pharmaceutical Chemistry Responsibility  Head of Foreign Pharmacy Graduated Equivalency Unit (2023-2024)  Member of Examination Committee (2022- 2023)  Member, Iraqi Pharmacist Syndicate  Awards & Memberships  Achieving the accepted global standard in Internet and Computing Core Certification (IC3) The Training of Trainers (ToT) – University of Baghdad.

Qualifications

PhD Pharmaceutical Chemistry

Responsibility

PhD Lecturer

Awards and Memberships

PhD Pharmaceutical Chemistry

Research Interests

Pharmaceutical Chemistry

Academic Area

Pharmaceutical Sciences

Teaching materials
Material
College
Department
Stage
Download
Organic Chemistry
كلية الصيدلة
الكيمياء الصيدلانية
Stage 2
Organic pharmaceutical chemistry
كلية الصيدلة
الكيمياء الصيدلانية
Stage 3
Teaching

Aromatic Compound Carboxylic acid and its derivatives Amine 1&2 Aldehyde and ketone Phenols 8-15 Metabolic Changes of Drugs and Related Organic Compounds 1-7 Effect of physical and chemical properties on drug efficacy

Supervision

اشراف طلاب ماجستير

Publication Date
Mon Apr 15 2024
Journal Name
Al-rafidain Journal Of Medical Sciences ( Issn 2789-3219 )
Evaluation of the Wound-Healing Activity and Apoptotic Induction of New Quinazolinone Derivatives
...Show More Authors

Background: Chemotherapeutic medication treatment for cancer is typically used in conjunction with other techniques as part of a routine regimen. It is well established that the capacity of different chemotherapeutic drugs to induce apoptosis is correlated with their anticancer efficacy. Quinazolinone-based drugs have demonstrated excellent responses from several cancer cell types. These substances have a lot of potential for use as building blocks in the creation of apoptosis inducers. Objective: To assess the new quinazolinone derivatives (M1 and M2) that were recently synthesized for their potential to halt wound healing and to use the acridine orange/propidium iodide (AO/PI) double stain to assess their capacity to induce apopto

... Show More
View Publication
Scopus Crossref
Publication Date
Sun Dec 25 2022
Synthesis, Molecular Docking Study and Cytotoxicity Evaluation of some Quinazolinone Derivatives as Nonclassical Antifolates and Potential Cytotoxic Agents
...Show More Authors

Abstract

A series of new 4(3H)-quinazolinone derivatives (S1-S4) were synthesized and characterized   by FTIR,1HNMR and 13CNMR .Their cytotoxic activity against a set of human cancer cell lines MCF-7 (breast) and A549 (lung) was evaluated using MTT assay. To detect their selectivity toward cancer cells, the compounds were also tested against epithelial cells derived from normal human fibroblast (NHF). Methotrexate (MTX) was used as a reference for comparison . All the tested compounds exhibited toxicity against the normal cells lower than cancer cells. All the tested compounds displayed higher cytotoxicity against lung cancer cell line (A549) than MTX with the most

... Show More
View Publication Preview PDF
Scopus (5)
Crossref (2)
Scopus Crossref
No Events Found